Viewing Study NCT03186495


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2025-12-29 @ 11:18 AM
Study NCT ID: NCT03186495
Status: COMPLETED
Last Update Posted: 2020-04-17
First Post: 2017-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Hormone Disorder View
None Adult Growth Hormone Deficiency View
None Growth Hormone Deficiency in Children View
Keywords: